Eikon reports Q3 2026 results, ESMO oncology data and new prostate cancer INDNov 12Quarterly updateAkari Therapeutics PlcAtrium Therapeutics
Xencor and Adlai Nortye add new oncology data as ESMO roundup widensOct 28Clinical readoutAdlai Nortye Group Ltd.Eikon TherapeuticsUpdated
Eikon Therapeutics reports Q2 2026 results with seven ESMO abstracts and melanoma trial progressAug 13Quarterly updateEikon Therapeutics